ETFsXtrackers Harvest MSCI China Tech 100 UCITS ETF 1C
Xtrackers
Xtrackers Harvest MSCI China Tech 100 UCITS ETF 1C
XCTE LSEAccumulatingLuxembourg
Last close · EUR
25.36EUR
-1.63% · -€0.42
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XCTEBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- -24.4%
- Sharpe 3Y
- 0.17
- Volatility 1Y
- 18.7%annualised
- Holdings
- 105Fund holdings
Performance
Compare
- XCTE-24.4%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XCTE | -9.7% | -16.0% | -20.3% | -18.1% | -24.4% | +14.6% | - |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.3% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | -10.1% | -20.9% | -31.1% | -34.4% | -40.2% | -60.9% | - |
Risk and return
Sharpe ratio · 3Y
0.17
Below MSCI World · 1.24- Return p.a.
- +3.8%
- Volatility
- 27.3%
- Max loss
- -26.5%Oct 2026
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
XCTE
0.17
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 41.1%
- Holdings
- 105
- As of
- 1XIAOMIKYG9830T10675.30%
- 2CHINA YANGTZE POWER LTD ACNE000001G875.06%
- 3JD.COM CLASS AKYG8208B10144.89%
- 4TENCENT HOLDINGSKYG8757216344.71%
- 5CAMBRICON TECHNOLOGIES CORPORATIONCNE1000041R84.37%
- 6ALIBABA GROUP HOLDINGKYG0171911424.29%
- 7FOXCONN INDUSTRIAL INTERNET LTD ACNE1000031P33.56%
- 8BAIDUKYG0703410483.19%
- 9LENOVO GROUPHK09920090652.90%
- 10CONTEMPORARY AMPEREX TECHNOLOGY ACNE1000036622.82%
Countries
China99.8%
- Largest
- 99.8%China
- Top 3
- 100.0%
- Effective number
- 1.01 / HHI
Market cap
Weight vs holdings
41.1%of the fund sits in the top 10 holdings
41.1%41.2%17.3%
WeightHoldings
104055
- Holdings 1-10
- Holdings 11-50
- Holdings 51-105
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
